Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$351.38 - $448.68 $219,612 - $280,425
-625 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$372.64 - $458.3 $139,740 - $171,862
375 Added 150.0%
625 $258,000
Q2 2021

Aug 13, 2021

BUY
$294.17 - $371.65 $73,542 - $92,912
250 New
250 $92,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Pittenger & Anderson Inc Portfolio

Follow Pittenger & Anderson Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pittenger & Anderson Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pittenger & Anderson Inc with notifications on news.